Biomarkers /
PTPN11
Overview
Protein tyrosine phosphatase, non-receptor type 11 (PTPN11) is a gene that encodes a protein that is in the protein tyrosine phosphatase (PTP) family and functions in cell growth and differentiation. Missense mutations, nonsense mutations, silent mutations, frameshift deletions and insertions, and in-frame deletions are observed in cancers such as endometrial cancer, intestinal cancer, and stomach cancer.
PTPN11 is altered in 1.31% of all cancers with lung adenocarcinoma, conventional glioblastoma multiforme, acute myeloid leukemia, colon adenocarcinoma, and glioblastoma having the greatest prevalence of alterations [3].
The most common alterations in PTPN11 are PTPN11 Mutation (1.23%), PTPN11 Exon 3 Mutation (0.44%), PTPN11 Exon 13 Mutation (0.32%), PTPN11 G503V (0.07%), and PTPN11 E76K (0.06%) [3].
Clinical Trials
Significance of PTPN11 in Diseases
References
1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta
2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.
3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.